https://www.fool.com/investing/general/2013/08/22/who-will-be-the-winner-in-the-fight-against-obesit.aspx
https://www.fool.com/investing/general/2013/10/03/is-alnylam-a-good-investment.aspx
https://www.fool.com/investing/general/2013/08/21/is-questcor-still-undervalued.aspx
https://www.fool.com/investing/general/2013/10/10/is-questcor-a-good-investment.aspx
https://www.fool.com/investing/general/2013/10/07/should-you-invest-in-orexigen.aspx
https://www.fool.com/investing/general/2013/10/21/is-isis-pharmaceuticals-a-good-investment.aspx
https://www.fool.com/investing/general/2013/11/12/is-arena-pharmaceuticals-making-progress.aspx
https://www.fool.com/investing/general/2013/10/25/is-alexion-pharmaceuticals-a-good-investment.aspx
https://www.fool.com/investing/general/2013/11/04/questcor-is-a-solid-investment.aspx
